Polen Capital Management Llc released its “Polen Focus Growth Strategy” Q4 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the Polen Focus Growth strategy delivered a -1 ...

Analysts on Wall Street project that Eli Lilly (LLY) will announce quarterly earnings of $6.99 per share in its forthcoming report, representing an increase of 31.4% year over year. Revenues are ...

We expect to launch Mounjaro in new markets outside the U.S. and Europe throughout the year. Mounjaro international revenue will contribute to overall performance more significantly in the second part ...

In the lead-up to its upcoming quarterly earnings report, Eli Lilly and Company is making significant moves to bolster its development pipeline. The pharmaceuti ...

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...

Is there another beat-and-raise in the pharmaceutical giant's near future?

Eli Lilly looks undervalued as earnings forecasts rise and GLP-1 catalysts near. Read the full analysis here of LLY stock.

The target action date for orforglipron is now April 10.

Novo Nordisk (NVO) may see a post-earnings dip as Q4 includes conservative 2026 guidance despite oral Wegovy momentum. Click ...